James Schoeneck
Net worth: 289 330 $ as of 2026-05-30
Net worth: 289 330 $ as of 2026-05-30
James A. Schoeneck is a businessperson who has been at the head of 5 different companies. Presently, Mr. Schoeneck holds the position of Chairman of FibroGen, Inc. He is also on the board of Calidi Biotherapeutics, Inc. In his past career James A. Schoeneck occupied the position of Chief Executive Officer of BrainCells, Inc., President, Chief Executive Officer & Director at Assertio Therapeutics, Inc., Chief Executive Officer of ActivX Biosciences, Inc., President, Chief Executive & Operating Officer at Prometheus Laboratories, Inc., Vice President & General Manager-Immunology at Centocor, Inc., Principal at KYORIN Pharmaceutical Co., Ltd. and Director-Marketing & Product Group at Rhone-Poulenc Rorer, Inc. James A. Schoeneck received an undergraduate degree from Jacksonville State University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
KYNTRA BIO, INC. 0.98% | 2026-06-11 | 39,666 ( 0.98% ) | 273 695 $ | 2026-05-30 |
| 2026-04-16 | 84,514 ( 2.36% ) | 15 635 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| KYNTRA BIO, INC. | Chairman | 2020-01-05 |
| CALIDI BIOTHERAPEUTICS, INC. | Chairman | 2025-03-31 |
| CONNECT BIOPHARMA HOLDINGS LIMITED | Director/Board Member | 2025-07-21 |
Calidi Biotherapeutics, Inc. (United States)
Calidi Biotherapeutics, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage immuno-oncology company | Director/Board Member | 2020-06-30 |
| Companies | Position | End |
|---|---|---|
| ANAPTYSBIO, INC. | Director/Board Member | 2018-03-18 |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Chief Executive Officer | 2017-03-27 |
BrainCells, Inc.
BrainCells, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Chief Executive Officer | 2010-12-31 |
ActivX Biosciences, Inc.
ActivX Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drug molecule for hematology, oncology, metabolic and inflammatory diseases | Chief Executive Officer | 2004-11-30 |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel pharmaceutical and diagnostic products | Chief Executive Officer | 2002-12-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 13 |
|---|---|
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Health Technology |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
BrainCells, Inc.
BrainCells, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
AnaptysBio, Inc.
AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
KYORIN Pharmaceutical Co. Ltd. (old)
KYORIN Pharmaceutical Co. Ltd. (old) Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets human pharmaceuticals | Health Technology |
FibroGen, Inc.
FibroGen, Inc. Pharmaceuticals: MajorHealth Technology Develops biotechnology-based drugs | Health Technology |
ActivX Biosciences, Inc.
ActivX Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drug molecule for hematology, oncology, metabolic and inflammatory diseases | Health Technology |
Jacksonville State University
Jacksonville State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel pharmaceutical and diagnostic products | Health Technology |
Calidi Biotherapeutics, Inc. (United States)
Calidi Biotherapeutics, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage immuno-oncology company | Commercial Services |
Connect Biopharma Holdings Ltd.
Connect Biopharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Calidi Biotherapeutics, Inc.
Calidi Biotherapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies which attacks solid tumors | Health Technology |
Select your edition
All financial news and data tailored to specific country editions